EUVIMEDEUVIMED entdecken
Crossref

Oral administration of herbal oligonucleotide drug JGL ‐ sRNA ‐h7 ameliorates hyperglycemia in db/db mice and beagle dogs

Kegong Tang, Xiaona Wang, Zhenyu Jiang, Mingrui Chen, Xingyu Deng, Song Mei, Yiming Ma, Xinyi Du, Shaoting Guo, Yexuan Lin, Yixin Dong, Dengyuan Liu und 2 weitere

IUBMB Life · 2024

DOI: 10.1002/iub.2859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Kegong Tang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Pe…. Hauptthemen laut MEDLINE: Hyperglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Endowment Fund, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health (111 Center).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus is a prevalent metabolic disease, posing a considerable threat to public health. Oligonucleotide drugs have proven to be a promising field of therapy for the diseases. In this study, we reported that a herbal small RNA (sRNA), JGL‐sRNA‐h7 (B34735529, F1439.L002444.A11), could exhibit potent hypoglycemic effects by targeting glucose‐6‐phosphatase. Oral administration of sphingosine (d18:1)‐JGL‐sRNA‐h7 bencaosomes ameliorated hyperglycemia and diabetic kidney injury better than metformin in db/db mice. Furthermore, glucose tolerance was also improved in sphingosine (d18:1)‐JGL‐sRNA‐h7 bencaosomes‐treated beagle dogs. Our study indicates that JGL‐sRNA‐h7 could be a promising hypoglycemic oligonucleotide drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaHypoglycemic AgentsAnimalsDogsMaleMiceAdministration, OralBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Mice, Inbred C57BLOligonucleotides

Stichwörter der Autor:innen

hyperglycemiaoligonucleotide drugoral administration

Substanzen

Blood GlucoseHypoglycemic AgentsOligonucleotides

Autor:innen und Institutionen

  • State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Chengyu Jiang

Förderung

  • National Natural Science Foundation of China
  • CAMS Endowment Fund
  • Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health (111 Center)
  • State Key Laboratory Special Fund
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • Fundamental Research Funds for Central Universities

Zitieren

APA

Tang, K., Wang, X., Jiang, Z., Chen, M., Deng, X., Mei, S., Ma, Y., Du, X., Guo, S., Lin, Y., Dong, Y., Liu, D., Xu, L., & Jiang, C. (2024). Oral administration of herbal oligonucleotide drug JGL ‐ sRNA ‐h7 ameliorates hyperglycemia in db/db mice and beagle dogs. IUBMB Life. https://doi.org/10.1002/iub.2859

Vancouver

Tang K, Wang X, Jiang Z, Chen M, Deng X, Mei S, et al. Oral administration of herbal oligonucleotide drug JGL ‐ sRNA ‐h7 ameliorates hyperglycemia in db/db mice and beagle dogs. IUBMB Life. 2024. doi:10.1002/iub.2859

BibTeX
@article{Tang2024,
  author = {Tang, Kegong and Wang, Xiaona and Jiang, Zhenyu and Chen, Mingrui and Deng, Xingyu and Mei, Song and Ma, Yiming and Du, Xinyi and Guo, Shaoting and Lin, Yexuan and Dong, Yixin and Liu, Dengyuan and Xu, Longxin and Jiang, Chengyu},
  title = {Oral administration of herbal oligonucleotide drug JGL ‐ sRNA ‐h7 ameliorates hyperglycemia in db/db mice and beagle dogs},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2859}
}
Kostenlos starten →